Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverEBO.AX
HealthcareASXAUD

EBOS Group Limited

A$0012345678900123456789.0012345678900123456789+1.3%
52w low (est.) A$15.19A$22.41 52w high (est.)
Market data · updated 1h ago
Peers
Market data
Market cap
AUD2.70B
52w range
AUD15.68 - AUD38.23
Beta
0.15
Sector
Healthcare
Data quality
100/100
Valuation
P/E ratio
18.5x
DCF fair value
AUD18.92
Margin of safety
+3.7%
Forward P/E
15.5x
PEG ratio
4.39
Dividend yield
4.80%
Quality & efficiency
Moat score
32/100
Return on equity
9.0%
Profit margin
1.8%
Debt / equity
0.68
Growth & analysts
Revenue growth
+13.0%
Analyst target
AUD24.48
Target upside
+34.1%
Analysts
4
Run the 10-point checklist before you buy How these numbers are made

About EBOS Group Limited

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Valuation

ValueGrowthProfitHealthIncome59QUALITY
Overall Rating
38
Reduce
Reduce

Derived from filed metrics · High confidence (100% of the inputs available)

Moat Score32
DCF Intrinsic Value
AUD18.92+3.7% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
AUD2.70B
P/E Ratio
18.5
Dividend Yield
4.80%
Revenue Growth
+13.0%
Profit Margin
1.8%
ROE
9.0%
Debt / Equity
0.68
Beta
0.15
Dividend AristocratsBeaten Down
vs Healthcare sector:P/E 18 vs 28 · cheaperMoat 32 vs 7Yield 4.80% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · EBO.AX